Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2009
12/31/2009US20090325931 Use of cdk inhibitors for the treatment of granulocyte mediated disorders
12/31/2009US20090325911 Use of Androgens for the Treatment of Parkinson's Disease
12/31/2009US20090325897 Designer therapy of pancreatic tumors
12/31/2009US20090325887 Peptides and regulation of calcium channels
12/31/2009US20090325886 Wt1 modified peptide
12/31/2009US20090325883 Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses
12/31/2009US20090325882 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325877 Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer
12/31/2009US20090325876 Use of lipid conjugates in the treatment of diseases associated with vasculature
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325868 Materials And Methods For FOXP3 Tumor Suppression
12/31/2009US20090325867 Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (trail) variants
12/31/2009US20090325804 Novel glyphosate-n-acetyltransferase (gat) genes
12/31/2009US20090325297 Method for inhibiting expression of a protein in a hepatocyte
12/31/2009US20090325296 Electrospun electroactive polymers for regenerative medicine applications
12/31/2009US20090325295 In-vitro mechanical loading of musculoskeletal tissues
12/31/2009US20090325294 Single pluripotent stem cell culture
12/31/2009US20090325293 Treatment of pluripotent cells
12/31/2009US20090325292 Functional polyglycolide nanoparticles derived from unimolecular micelles
12/31/2009US20090325291 METHOD OF PREPARING siRNAs FOR SELECTIVE INHIBITION OF TARGET mRNA ISOTYPES
12/31/2009US20090325290 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
12/31/2009US20090325289 Process for the multiplication of stem cells
12/31/2009US20090325288 Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
12/31/2009US20090325287 Methods for Obtaining High Viable Cell Density in Mammalian Cell Culture
12/31/2009US20090325286 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325285 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325264 Engineered Delta-15-Fatty Acid Desaturases
12/31/2009US20090325216 Process for the Preparation of Multicellular Spheroids
12/31/2009US20090325213 Diagnostic and therapeutic application of ctl and nk functionally selected cells
12/31/2009US20090325207 Novel phosphodiesterase and gene thereof
12/31/2009US20090325200 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer
12/31/2009US20090325198 Non-Denaturing Lysis Reagent For Use With Capture-In-Solution Immunoassay
12/31/2009US20090325180 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
12/31/2009US20090325168 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
12/31/2009US20090324797 Modulating plant oil levels
12/31/2009US20090324759 Immune enhancement by seed oil and/or seed flour
12/31/2009US20090324700 Methods and compositions for the inhibition of cathepsins
12/31/2009US20090324681 Vascularization Enhanced Graft Constructs
12/31/2009US20090324651 Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System
12/31/2009US20090324649 Leishmania vaccine using sand fly salivary immunogen
12/31/2009US20090324634 Trypanosoma Antigens, Vaccine Compositions, and Related Methods
12/31/2009US20090324630 Fusion multiviral chimeric antigen
12/31/2009US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009US20090324623 Two-component genome flavivirus and uses thereof
12/31/2009US20090324618 Novel signature self renewal gene expression programs
12/31/2009US20090324609 Method of treating autoimmune disease with mesenchymal stem cells
12/31/2009US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof
12/31/2009US20090324605 Interferon alpha antibodies and their uses
12/31/2009US20090324602 Anti-fn14 antibodies and uses thereof
12/31/2009US20090324601 Targeted binding agents directed to pdgfr-alpha and uses thereof
12/31/2009US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders
12/31/2009US20090324589 Methods for controlling blood pharmacokinetics of antibodies
12/31/2009US20090324583 Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation
12/31/2009US20090324579 Anti-apoptotic protein antibodies
12/31/2009US20090324576 Phage derived antimicrobial activities
12/31/2009US20090324575 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
12/31/2009US20090324567 Leukocyte Cell Banks
12/31/2009US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor
12/31/2009US20090324562 Defensin Proteins
12/31/2009US20090324561 Cells exhibiting neuronal progenitor cell characteristics and methods of making them
12/31/2009US20090324560 Method for preparation of cartilage cell
12/31/2009US20090324559 Methods and platforms for drug discovery
12/31/2009US20090324557 Method to induce and expand therapeutic alloantigen-specific human regulatory t cells in large-scale
12/31/2009US20090324556 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
12/31/2009US20090324555 Neural Stem Cells
12/31/2009US20090324553 Chimeric Viral Envelopes
12/31/2009US20090324549 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases
12/31/2009US20090324546 Method for modulating gene expression by modifying the cpg content
12/31/2009US20090324501 Vaccine Carrier
12/31/2009US20090324500 Screen for inflammatory response modulators
12/31/2009DE112007000030B4 Verfahren zur Isolierung einer Haarfollikelstammzelle und Zusammensetzung für die Haarreproduktion A method for isolating a Haarfollikelstammzelle and Hair composition Reproduction
12/30/2009WO2009158716A1 Improved protein production and storage in plants
12/30/2009WO2009158614A1 Novel astrovirus
12/30/2009WO2009157771A2 Antibody producing non-human mammals
12/30/2009WO2009157610A1 Selenium dedifferentiated cell, preparation method and usage thereof
12/30/2009WO2009157602A1 The recombinant chimeric protein for the diagnosis of taenia solium infection and diagnostic kits comprising the same toward a standardized serodiagnosis of taenia solium neurocysticercosis
12/30/2009WO2009157593A1 Method of efficiently establishing induced pluripotent stem cells
12/30/2009WO2009157585A1 Support for freeze preservation of animal cells and biodevice for freeze preservation and method for freeze preservation using the same
12/30/2009WO2009157562A1 Method for establishment of adult pancreatic stem cell, and method for differentiation of adult pancreatic stem cell
12/30/2009WO2009157385A1 Method for distinguishing and sorting cells and device therefor
12/30/2009WO2009157212A1 Method for dispensation of active factor to cultured cells, microchamber, microchamber array, culture vessel, and apparatus for dispensation of active factor
12/30/2009WO2009157209A1 Cryopreservative composition for cell and tissue
12/30/2009WO2009157201A1 Method and kit for preparing ips cells
12/30/2009WO2009156495A1 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using
12/30/2009WO2009156413A1 Established human brown adipocyte line and method for differentiation from an hmads cell line
12/30/2009WO2009156411A1 Cellular differentiation process and its use for blood vessel build-up
12/30/2009WO2009156398A1 Methods for preparing human skin substitutes from human pluripotent stem cells
12/30/2009WO2009156151A1 Mesoangioblast-like cell as well as methods and uses relating thereto
12/30/2009WO2009156137A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009WO2009137844A3 Pancreatic endocrine progenitor cells derived from pluripotent stem cells
12/30/2009WO2009137598A3 Methods and composition for modulating hematopoietic stem cell migration
12/30/2009WO2009137242A9 Trichoplusia ni cell line and methods of use
12/30/2009WO2009137109A9 Endorphin therapy compositions and methods
12/30/2009WO2009136283A3 Multipotent adult stem cell population
12/30/2009WO2009136173A3 Biomimetic cell scaffolds
12/30/2009WO2009126934A3 Detection and tratment of pancreatic, ovarian and other cancers
12/30/2009WO2009124281A3 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis